透過您的圖書館登入
IP:18.218.38.125
  • 期刊
  • Ahead-of-Print

Dietary iron and zinc intakes and nonalcoholic fatty liver disease: A meta-analysis

本文正式版本已出版,請見:10.6133/apjcn.202112_30(4).0017

摘要


Background and Objectives: The differences of dietary iron and zinc intakes between patients with nonalcoholic fatty liver disease (NAFLD) and controls remain controversial. The meta-analysis aimed to explore the differences of dietary iron and zinc intakes between NAFLD patients and healthy subjects. Methods and Study Design: A systematic literature search was performed up to July 2021 in databases of PubMed, Embase, Web of Science, Cochrane Library, Chinese National Knowledge Infrastructure (CNKI), and Wanfang. Using a random-effects model, the differences of dietary iron and zinc intakes between cases and controls were calculated as standardized mean differences (SMDs) with 95% confidence intervals (CIs). A total of 21 studies from 19 articles with 6639 cases were included. Results: The pooled estimate showed no difference in dietary iron consumption in the NAFLD groups compared with control groups. The difference became significant in Asia (SMD=0.16; 95% CI: 0.04, 0.28; I^2=89.1%; p_(heterogeneity)< 0.001) as well as in cross-sectional studies (SMD=0.12; 95% CI: 0.07, 0.17; I^2=4.7%; p_(heterogeneity) = 0.350). The difference in dietary zinc intake between cases and controls was not significant. We noticed a statistically significant increase of dietary zinc intake in NAFLD compared to controls in studies using food-frequency questionnaire (FFQ) to evaluate dietary intake (SMD=0.15; 95% CI: 0.10, 0.20; I^2=12.2%; p_(heterogeneity)=0.332). Conclusions: Our findings indicated that dietary iron intake in patients with NAFLD was higher than healthy subjects in Asia.

延伸閱讀